Australian Broker Call
Produced and copyrighted by at www.fnarena.com
September 16, 2020
Access Broker Call Report Archives here
COMPANIES DISCUSSED IN THIS ISSUE
Click on symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1).
Last Updated: 05:00 PM
Your daily news report on the latest recommendation, valuation, forecast and opinion changes.
This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.
For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE
Today's Upgrades and Downgrades
CGF - | Challenger | Upgrade to Outperform from Neutral | Credit Suisse |
JBH - | JB Hi-Fi | Upgrade to Outperform from Neutral | Macquarie |
Overnight Price: $28.29
Credit Suisse rates ALL as Outperform (1) -
Credit Suisse asserts real money gambling is going digital in the US, and fast. Originally, the broker assessed this would be a narrow content adjacency for Aristocrat Leisure but it appears to have gone the other way and is now a systems market critical to the future.
The broker believes the company should act and perhaps sacrifice short-term returns for a strong market position in real money internet gaming.
The broker incorporates $1bn for an acquisition and upgrades long-term cash net profit growth in its forecasts. Outperform maintained. Target rises to $30 from $28.
Target price is $30.00 Current Price is $28.29 Difference: $1.71
If ALL meets the Credit Suisse target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $30.52, suggesting upside of 4.4% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY20:
Credit Suisse forecasts a full year FY20 dividend of 0.00 cents and EPS of 74.24 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 69.8, implying annual growth of -36.3%. Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A. Current consensus EPS estimate suggests the PER is 41.9. |
Forecast for FY21:
Credit Suisse forecasts a full year FY21 dividend of 24.30 cents and EPS of 116.58 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 109.8, implying annual growth of 57.3%. Current consensus DPS estimate is 25.2, implying a prospective dividend yield of 0.9%. Current consensus EPS estimate suggests the PER is 26.6. |
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CGF CHALLENGER LIMITED
Wealth Management & Investments
More Research Tools In Stock Analysis - click HERE
Overnight Price: $3.63
Credit Suisse rates CGF as Upgrade to Outperform from Neutral (1) -
Credit Suisse assesses Challenger is trading at a significant discount to book value. While there may be some downside risk to FY21 earnings and the first half is likely to be challenging, there is significant valuation support.
Moreover, the broker notes potential for a positive catalyst with the government's retirement income review, possibly due around the budget in October.
Rating is upgraded to Outperform from Neutral. Target is steady at $4.25.
Target price is $4.25 Current Price is $3.63 Difference: $0.62
If CGF meets the Credit Suisse target it will return approximately 17% (excluding dividends, fees and charges).
Current consensus price target is $4.35, suggesting upside of 14.9% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY21:
Credit Suisse forecasts a full year FY21 dividend of 19.00 cents and EPS of 37.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 37.1, implying annual growth of N/A. Current consensus DPS estimate is 20.0, implying a prospective dividend yield of 5.3%. Current consensus EPS estimate suggests the PER is 10.2. |
Forecast for FY22:
Credit Suisse forecasts a full year FY22 dividend of 21.00 cents and EPS of 41.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 41.3, implying annual growth of 11.3%. Current consensus DPS estimate is 24.0, implying a prospective dividend yield of 6.3%. Current consensus EPS estimate suggests the PER is 9.2. |
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CSL CSL LIMITED
Pharmaceuticals & Biotech/Lifesciences
More Research Tools In Stock Analysis - click HERE
Overnight Price: $287.24
Credit Suisse rates CSL as Outperform (1) -
Credit Suisse believes the pandemic will promote a sustained increase in flu vaccination rates over the next 2-3 years.
The broker calculates industry volume growth of 10% in FY21 and Seqirus should gain share, with seasonal vaccine volume growth of 14% and revenue growth of 19%.
CSL is launching Fluad QIV in the US in FY21, in Europe in FY22, and a significant shift to this version is considered likely, aiding margin. Credit Suisse retains an Outperform rating and $333 target.
Target price is $333.00 Current Price is $287.24 Difference: $45.76
If CSL meets the Credit Suisse target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $310.39, suggesting upside of 6.6% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY21:
Credit Suisse forecasts a full year FY21 dividend of 310.01 cents and EPS of 730.74 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 675.7, implying annual growth of N/A. Current consensus DPS estimate is 296.5, implying a prospective dividend yield of 1.0%. Current consensus EPS estimate suggests the PER is 43.1. |
Forecast for FY22:
Credit Suisse forecasts a full year FY22 dividend of 358.73 cents and EPS of 819.31 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 763.2, implying annual growth of 12.9%. Current consensus DPS estimate is 337.1, implying a prospective dividend yield of 1.2%. Current consensus EPS estimate suggests the PER is 38.2. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $3.33
Macquarie rates HLS as Outperform (1) -
Macquarie reviews the pathology margins, noting these have declined over time but expansion is now likely to FY23.
Contributions from Covid-19 testing as well as a recovery in base volumes are positive indicators going forward. There are also opportunities for growth, given an improved balance sheet.
A demonstration of operating leverage within pathology will be a catalyst for a multiple re-rating, in the broker's view. Outperform retained. Target rises to $3.80 from $3.70.
Target price is $3.80 Current Price is $3.33 Difference: $0.47
If HLS meets the Macquarie target it will return approximately 14% (excluding dividends, fees and charges).
Current consensus price target is $3.51, suggesting upside of 4.9% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY21:
Macquarie forecasts a full year FY21 dividend of 3.80 cents and EPS of 13.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 15.7, implying annual growth of N/A. Current consensus DPS estimate is 5.6, implying a prospective dividend yield of 1.7%. Current consensus EPS estimate suggests the PER is 21.3. |
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 7.20 cents and EPS of 15.70 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 16.8, implying annual growth of 7.0%. Current consensus DPS estimate is 7.6, implying a prospective dividend yield of 2.3%. Current consensus EPS estimate suggests the PER is 19.9. |
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $46.76
Macquarie rates JBH as Upgrade to Outperform from Neutral (1) -
Consumer spending was elevated over the September quarter as durables benefited from constraints on travel and services. Moreover, Macquarie points out a new 5G handset and console launches will create interest going into Christmas.
The broker's research suggests the online offering from JB Hi-Fi handled demand better over the second half compared with many peers.
Consumer durable expenditure is likely to remain elevated for the rest of 2020 and provide upside for the short term. Hence, the broker upgrades to Outperform from Neutral. Target is raised to $53.70 from $48.80.
Target price is $53.70 Current Price is $46.76 Difference: $6.94
If JBH meets the Macquarie target it will return approximately 15% (excluding dividends, fees and charges).
Current consensus price target is $48.18, suggesting upside of 1.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY21:
Macquarie forecasts a full year FY21 dividend of 152.00 cents and EPS of 272.60 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 274.5, implying annual growth of 4.3%. Current consensus DPS estimate is 176.3, implying a prospective dividend yield of 3.7%. Current consensus EPS estimate suggests the PER is 17.4. |
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 148.00 cents and EPS of 266.30 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 251.9, implying annual growth of -8.2%. Current consensus DPS estimate is 164.3, implying a prospective dividend yield of 3.4%. Current consensus EPS estimate suggests the PER is 18.9. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $11.90
Morgan Stanley rates LLC as Resume coverage with Equal-weight (3) -
Morgan Stanley believes the focus on urbanisation will appeal. However, the timing of the ramp up may depend on securing tenant pre-commitments and this will not be easy in the short term.
The financial close of the sale of engineering means Lendlease is now a cleaner business with a sharp focus on property development, while the business plan is attractive in the broker's view.
Morgan Stanley resumes coverage with an Equal-weight rating and $13.55 target. Industry view: In-line.
Target price is $13.55 Current Price is $11.90 Difference: $1.65
If LLC meets the Morgan Stanley target it will return approximately 14% (excluding dividends, fees and charges).
Current consensus price target is $13.89, suggesting upside of 17.5% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY21:
Morgan Stanley forecasts a full year FY21 dividend of 31.00 cents and EPS of 70.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 71.3, implying annual growth of N/A. Current consensus DPS estimate is 34.1, implying a prospective dividend yield of 2.9%. Current consensus EPS estimate suggests the PER is 16.6. |
Forecast for FY22:
Morgan Stanley forecasts a full year FY22 dividend of 38.00 cents and EPS of 84.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 95.6, implying annual growth of 34.1%. Current consensus DPS estimate is 46.4, implying a prospective dividend yield of 3.9%. Current consensus EPS estimate suggests the PER is 12.4. |
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $6.00
Morgans rates OPC as Hold (3) -
Uniti Group ((UWL)) has revised its OptiComm offer to $5.85, which consists of $4.835 in cash (including the $0.10 dividend) plus 0.80537 Uniti Group shares per 1 OptiComm share. The Uniti Group share component was valued at $1.01 (using a $1.26 Uniti Group share price).
First State Super (FSS) has until 18 September to make a formal offer, its current one being highly conditional.
The OptiComm board recommends in favour of Uniti Group.
Morgans continues to recommend holding to see what happens next. The broker notes the Uniti Group's 19.5% stake in OptiComm will make thinks harder for First State Super. An increase in Uniti Group's share price increases the offer price.
The Hold rating is unchanged and the target price is increased to $5.85 from $5.10.
Target price is $5.85 Current Price is $6.00 Difference: minus $0.15 (current price is over target).
If OPC meets the Morgans target it will return approximately minus 3% (excluding dividends, fees and charges - negative figures indicate an expected loss).
The company's fiscal year ends in June.
Forecast for FY21:
Morgans forecasts a full year FY21 dividend of 8.00 cents and EPS of 13.00 cents. |
Forecast for FY22:
Morgans forecasts a full year FY22 dividend of 8.00 cents and EPS of 12.00 cents. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates OPC as Hold (3) -
Under the revised scheme of arrangement Uniti Group ((UWL)) has included a larger cash component. This implies a 15% premium to the prior cash option.
The company has acquired a 19.5% beneficial interest in OptiComm shares, creating a blocking position which Ord Minnett suggests makes a competing bid more challenging.
Ord Minnett maintains its Hold rating with a target price of $5.42 as the process continues.
Current Price is $6.00. Target price not assessed.
The company's fiscal year ends in June.
Forecast for FY21:
Ord Minnett forecasts a full year FY21 dividend of 8.20 cents and EPS of 22.50 cents. |
Forecast for FY22:
Ord Minnett forecasts a full year FY22 dividend of 9.70 cents and EPS of 26.60 cents. |
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $9.28
Ord Minnett rates QBE as Accumulate (2) -
In a test case brought by the UK Financial Conduct Authority against insurers regarding business interruption claims, the High Court appears to have largely ruled in favour of the insured.
Ord Minnett notes QBE Insurance appears to have adverse findings for one policy type and more favourable findings for two others.
Pending further clarity, the broker retains an Accumulate rating and $12 target.
This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.
Target price is $12.00 Current Price is $9.28 Difference: $2.72
If QBE meets the Ord Minnett target it will return approximately 29% (excluding dividends, fees and charges).
Current consensus price target is $11.45, suggesting upside of 24.4% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY20:
Ord Minnett forecasts a full year FY20 dividend of 10.33 cents and EPS of minus 37.35 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is -42.3, implying annual growth of N/A. Current consensus DPS estimate is 25.2, implying a prospective dividend yield of 2.7%. Current consensus EPS estimate suggests the PER is N/A. |
Forecast for FY21:
Ord Minnett forecasts a full year FY21 dividend of 36.91 cents and EPS of 86.95 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 72.3, implying annual growth of N/A. Current consensus DPS estimate is 63.0, implying a prospective dividend yield of 6.8%. Current consensus EPS estimate suggests the PER is 12.7. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.33
Morgans rates RED as Add (1) -
Red 5 has released the King of the Hills (KOTH) feasibility study, outlining a 16-year mine life producing 2.35Moz of gold at an average all-in sustaining cost (AISC) of $1,415/oz. The project development capital is estimated at $226m.
These results appear very positive to Morgans and show a pathway for the company to become a 250koz per annum producer by FY23. The updated ore reserve is also considered to underpin production.
The broker expects the company has sufficient cash reserves to develop KOTH if it can secure $165m of debt funding, which management is currently working toward.
The Add rating is unchanged and the target price is increased to $0.524 from $0.502.
Target price is $0.52 Current Price is $0.33 Difference: $0.194
If RED meets the Morgans target it will return approximately 59% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY20:
Morgans forecasts a full year FY20 dividend of 0.00 cents and EPS of 0.50 cents. |
Forecast for FY21:
Morgans forecasts a full year FY21 dividend of 0.00 cents and EPS of 0.30 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Ord Minnett rates SCG as Hold (3) -
Ord Minnett notes a report Scentre Group is proposing to issue subordinated notes. The hybrids would be issued in the US and Europe.
The broker expects the market to view such a move favourably, given uncertainty as to whether the balance sheet could handle further devaluations.
The hybrid issue would alleviate a lot of concerns, presuming it is treated as equity in gearing calculations.
Ord Minnett maintains its Hold recommendation with a $2.20 target price.
This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.
Target price is $2.20 Current Price is $2.21 Difference: minus $0.01 (current price is over target).
If SCG meets the Ord Minnett target it will return approximately minus 0% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $2.34, suggesting upside of 2.9% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY20:
Ord Minnett forecasts a full year FY20 dividend of 10.00 cents and EPS of 15.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 15.3, implying annual growth of -31.4%. Current consensus DPS estimate is 7.1, implying a prospective dividend yield of 3.1%. Current consensus EPS estimate suggests the PER is 14.8. |
Forecast for FY21:
Ord Minnett forecasts a full year FY21 dividend of 17.00 cents and EPS of 20.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 20.6, implying annual growth of 34.6%. Current consensus DPS estimate is 17.1, implying a prospective dividend yield of 7.5%. Current consensus EPS estimate suggests the PER is 11.0. |
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $3.28
Macquarie rates SDF as Outperform (1) -
Macquarie assesses Steadfast Group is trading at a discount to comparable historical valuation. Guidance for FY21 implies growth in operating earnings (EBITA) of 7.3% and, in the broker's view, supports 5-10% growth in earnings per share.
The long track record of EPS growth around 10% suggests the current discount is not justified, and Macquarie retains an Outperform rating and $3.90 target.
Target price is $3.90 Current Price is $3.28 Difference: $0.62
If SDF meets the Macquarie target it will return approximately 19% (excluding dividends, fees and charges).
Current consensus price target is $3.96, suggesting upside of 18.6% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY21:
Macquarie forecasts a full year FY21 dividend of 10.10 cents and EPS of 16.80 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 16.3, implying annual growth of N/A. Current consensus DPS estimate is 10.1, implying a prospective dividend yield of 3.0%. Current consensus EPS estimate suggests the PER is 20.5. |
Forecast for FY22:
Macquarie forecasts a full year FY22 dividend of 10.80 cents and EPS of 17.90 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 17.3, implying annual growth of 6.1%. Current consensus DPS estimate is 10.8, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 19.3. |
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $1.42
Ord Minnett rates UWL as Buy (1) -
Uniti Group has increased its offer for OptiComm ((OPC)) by 15%, raising the cash portion of the offer. Ord Minnett believes this provides a differentiating factor for those investors looking to benefit from the combined synergies.
The company has also purchased a 19.5% blocking interest which establishes a meaningful stake against potentially an increase in the competing offer.
Ord Minnett forecasts accretion of 17% under the revised terms and maintains a Buy rating. Target is reduced to $1.94 from $2.03.
Target price is $1.94 Current Price is $1.42 Difference: $0.52
If UWL meets the Ord Minnett target it will return approximately 37% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY21:
Ord Minnett forecasts a full year FY21 EPS of 6.70 cents. |
Forecast for FY22:
Ord Minnett forecasts a full year FY22 EPS of 9.80 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $1.59
Morgan Stanley rates VEA as Overweight (1) -
Morgan Stanley assesses fuel volumes are likely to recover in late 2020 as Victoria comes out of lockdown, while retail margins continue to outperform forecasts and compensate for lower volumes.
The broker estimates more leverage for Viva Energy from higher margins, with the Australian government's fuel package expected to be supportive.
Overweight retained. Target is $2.55. Industry view is Cautious.
Target price is $2.55 Current Price is $1.59 Difference: $0.96
If VEA meets the Morgan Stanley target it will return approximately 60% (excluding dividends, fees and charges).
Current consensus price target is $2.09, suggesting upside of 29.0% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY20:
Morgan Stanley forecasts a full year FY20 dividend of 1.30 cents and EPS of 1.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 0.4, implying annual growth of -93.1%. Current consensus DPS estimate is 3.3, implying a prospective dividend yield of 2.0%. Current consensus EPS estimate suggests the PER is 405.0. |
Forecast for FY21:
Morgan Stanley forecasts a full year FY21 dividend of 9.50 cents and EPS of 12.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 6.5, implying annual growth of 1525.0%. Current consensus DPS estimate is 5.2, implying a prospective dividend yield of 3.2%. Current consensus EPS estimate suggests the PER is 24.9. |
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Today's Price Target Changes
Company | Last Price | Broker | New Target | Prev Target | Change | |
ALL | Aristocrat Leisure | $29.24 | Credit Suisse | 30.00 | 28.00 | 7.14% |
HLS | Healius | $3.34 | Macquarie | 3.80 | 3.70 | 2.70% |
JBH | JB Hi-Fi | $47.67 | Macquarie | 53.70 | 48.80 | 10.04% |
LLC | Lendlease | $11.82 | Morgan Stanley | 13.55 | N/A | - |
OPC | Opticomm | $6.00 | Morgans | 5.85 | 5.10 | 14.71% |
Ord Minnett | N/A | 5.42 | -100.00% | |||
RED | Red 5 Ltd | $0.36 | Morgans | 0.52 | 0.50 | 4.80% |
UWL | Uniti Group | $1.42 | Ord Minnett | 1.94 | 2.03 | -4.43% |
Summaries
ALL | Aristocrat Leisure | Outperform - Credit Suisse | Overnight Price $28.29 |
CGF | Challenger | Upgrade to Outperform from Neutral - Credit Suisse | Overnight Price $3.63 |
CSL | CSL | Outperform - Credit Suisse | Overnight Price $287.24 |
HLS | Healius | Outperform - Macquarie | Overnight Price $3.33 |
JBH | JB Hi-Fi | Upgrade to Outperform from Neutral - Macquarie | Overnight Price $46.76 |
LLC | Lendlease | Resume coverage with Equal-weight - Morgan Stanley | Overnight Price $11.90 |
OPC | Opticomm | Hold - Morgans | Overnight Price $6.00 |
Hold - Ord Minnett | Overnight Price $6.00 | ||
QBE | QBE Insurance | Accumulate - Ord Minnett | Overnight Price $9.28 |
RED | Red 5 Ltd | Add - Morgans | Overnight Price $0.33 |
SCG | Scentre Group | Hold - Ord Minnett | Overnight Price $2.21 |
SDF | Steadfast Group | Outperform - Macquarie | Overnight Price $3.28 |
UWL | Uniti Group | Buy - Ord Minnett | Overnight Price $1.42 |
VEA | Viva Energy Group | Overweight - Morgan Stanley | Overnight Price $1.59 |
RATING SUMMARY
Rating | No. Of Recommendations |
1. Buy | 9 |
2. Accumulate | 1 |
3. Hold | 4 |
Wednesday 16 September 2020
Access Broker Call Report Archives here
Disclaimer:
The content of this information does in no way reflect the opinions of
FNArena, or of its journalists. In fact we don't have any opinion about
the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe
and comment on. By doing so we believe we provide intelligent investors
with a valuable tool that helps them in making up their own minds, reading
market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not
constitute an offer to sell or a solicitation to buy any security or other
financial instrument. FNArena employs very experienced journalists who
base their work on information believed to be reliable and accurate, though
no guarantee is given that the daily report is accurate or complete. Investors
should contact their personal adviser before making any investment decision.
Latest News
1 |
Monthly Listed Investment Trust Report – Oct 202412:00 PM - Australia |
2 |
The Case For Charter Hall11:30 AM - Australia |
3 |
Australian Listed Real Estate Tables – 07-10-202411:00 AM - Weekly Reports |
4 |
Australian Banks: When The End Of The Trend?10:38 AM - Feature Stories |
5 |
Weekly Ratings, Targets, Forecast Changes – 04-10-2410:00 AM - Weekly Reports |